Abeona Therapeutics (NASDAQ:ABEO) Lowered to “Sell” Rating by StockNews.com
Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Thursday. ABEO has been the subject of a number of other reports. HC Wainwright lifted their target price on Abeona Therapeutics from $15.00 to $20.00 and gave […]
Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Thursday. ABEO has been the subject of a number of other reports. HC Wainwright lifted their target price on Abeona Therapeutics from $15.00 to $20.00 and gave […]
